Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Farmers Insurance
Fish and Richardson

Generated: March 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016092

« Back to Dashboard

NDA 016092 describes EDECRIN, which is a drug marketed by Aton and is included in two NDAs. It is available from four suppliers. Additional details are available on the EDECRIN profile page.

The generic ingredient in EDECRIN is ethacrynic acid. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethacrynic acid profile page.
Summary for 016092
Ingredient:ethacrynic acid
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 016092
Medical Subject Heading (MeSH) Categories for 016092
Suppliers and Packaging for NDA: 016092
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EDECRIN ethacrynic acid TABLET;ORAL 016092 NDA KAISER FOUNDATION HOSPITALS 0179-0126 N 0179-0126-70
EDECRIN ethacrynic acid TABLET;ORAL 016092 NDA Aton Pharma, Inc. 25010-215 N 25010-215-15

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cantor Fitzgerald
Chinese Patent Office
Boehringer Ingelheim
Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.